Research articlesExercise treatment for depression: Efficacy and dose response
Introduction
The Global Burden of Disease study1 found that mild to moderate major depressive disorder (MDD) ranks second behind ischemic heart disease for years of life lost due to premature death or disability. Although effective pharmacologic and psychotherapeutic treatments for MDD are available, many people do not seek treatment or do not receive adequate treatment.2 National estimates indicate that only 23% of people with this disease seek treatment,2 and only 10% receive adequate treatment, in part because of the social stigma associated with treatment.3
Exercise may be a viable treatment because it can be recommended for most individuals, and does not carry a negative social stigma. However, exercise has not yet met established efficacy standards,4, 5 although some studies have demonstrated reductions in depressive symptoms with exercise.6, 7, 8, 9, 10 A recent randomized controlled trial (RCT)11 compared exercise, antidepressant medication, and combined medication and exercise in older adults with MDD and found that all treatments were effective. This study adequately diagnosed depression and treatment outcomes, but because exercise was done in a group setting, a question remains of whether social support influenced treatment response. Isolating the effects of exercise from social support, examining effects in different age groups, and quantifying the amount of exercise needed to reduce symptoms of MDD is important for establishing the efficacy of exercise as a monotherapy.
Using scores from the 17-item Hamilton Rating Scale for Depression (HRSD17)12, 13 as the primary outcome measure, our purpose was to test: (1) whether the mean change in HRSD17 score from baseline was greater after 12 weeks for active exercise conditions compared with an exercise placebo; and (2) whether there was a dose-response relation between the exercise doses and reduction in HRSD17 score. Secondary aims were to examine rates of treatment response (50% reduction in HRSD17 score) and rates of remission (HRSD17≤7).5, 14
Section snippets
Methods
The rationales for the study design and detailed methods have been published elsewhere15; the methods and design are briefly outlined here.
Results
Approximately 5% of the 1664 prescreened participants were ultimately randomized to treatment. Figure 1 shows the reasons for exclusion. A total of 80 participants were randomized to the four conditions—LD/3, LD/5, PHD/3, or PHD/5—or the exercise placebo control. For the two independent variables of energy expenditure and exercise frequency, this included 34 participants in the two LD conditions and 33 in the two PHD conditions, and 33 participants in the two 3-day/week conditions and 34
Discussion
The major finding was that the public health dose (PHD) of exercise is an effective monotherapy for mild to moderate MDD. In the efficacy analysis, mean HRSD17 scores at 12 weeks were reduced 47% from baseline for the PHD condition, significantly better than the LD and control conditions. Forty-six percent of participants in the PHD group had a therapeutic response to treatment, defined as a 50% reduction in baseline HRSD17 score, and 42% of the PHD group had remission of symptoms, defined as
References (28)
- et al.
Global mortality, disability, and the contribution of risk factorsGlobal Burden of Disease Study
Lancet
(1997) - et al.
Running as treatment for depression
Comp Psychiatry
(1979) - et al.
The DOSE study: exercise as treatment for depression: a clinical trial to examine efficacy and dose response
Control Clin Trials
(2002) - et al.
Screening for depression in well older adultsevaluation of a short form of the CES-D
Am J Prev Med
(1994) - et al.
Allocation concealment in randomised trialsdefending against deciphering
Lancet
(2002) - et al.
Comparing aerobic with nonaerobic forms of exercise in the treatment of clinical depressiona randomized trial
Comp Psychiatry
(1989) Mental healtha report of the Surgeon General
(1999)- et al.
Psychiatric disorders in Americathe Epidemiologic Catchment Area Study
(1991) - et al.
Depression in primary care. Vol. 1, Detection and diagnosis
Clinical practice guideline, Number 5
(1993) - et al.
Depression in primary care. Vol. 2, Treatment of major depression
(1993)
The role of aerobic exercise in the treatment of depression
Stress Med
Exercise and depression in the older adult
Nutr Clin Care
The effect of exercise on depressive symptoms in the moderately depressed elderly
Psychol Aging
Physical activity and personal characteristics associated with depression and suicide in American college men
Acta Psychiatr Scand Suppl
Cited by (1003)
Physical activity, suicidal ideation, suicide attempt and death among individuals with mental or other medical disorders: A systematic review of observational studies
2024, Neuroscience and Biobehavioral ReviewsThe effect of saffron and corrective exercises on depression and quality of life in women with multiple sclerosis: A randomized controlled clinical trial
2023, Multiple Sclerosis and Related DisordersAdaption of tele-behavioral activation to increase physical activity in depression: Protocol for iterative development and evaluation
2023, Contemporary Clinical Trials Communications
The full text of this article is available via AJPM Online at www.ajpm-online.net.